Evaluating the effects of different durations of myofascial release therapy on plantar fasciitis
Temporal Differences in Pain, Muscle Stiffness, and Function in Subjects With Plantar Fasciitis After Myofascial Release Therapy
NA · Universidad Católica del Maule · NCT06754982
This study is testing whether a 15-minute myofascial release therapy session is just as helpful as a 30-minute session for people with plantar fasciitis.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 18 Years to 60 Years |
| Sex | All |
| Sponsor | Universidad Católica del Maule (other) |
| Locations | 1 site (Talca, Maule Region) |
| Trial ID | NCT06754982 on ClinicalTrials.gov |
What this trial studies
This study investigates the impact of varying durations of myofascial release therapy on pain, muscle stiffness, and function in individuals diagnosed with plantar fasciitis. Participants will receive either a 15-minute or a 30-minute session of myofascial release to determine if the shorter duration is as effective as the longer one. The study aims to optimize treatment time while maintaining therapeutic benefits, focusing on individuals aged 18 to 60 with specific pain characteristics. The outcomes will be measured using pain intensity scales and functional assessments.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 to 60 diagnosed with unilateral plantar fasciitis experiencing moderate pain.
Not a fit: Patients who have undergone recent foot or ankle interventions or have other underlying causes of heel pain may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a more time-efficient treatment option for patients suffering from plantar fasciitis.
How similar studies have performed: Previous studies have shown positive results for myofascial release in treating plantar fasciitis, but this specific comparison of treatment durations is novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Study participants must be diagnosed with PF * Age between 18 to 60 years a clinical diagnosis of unilateral PF according to the clinical practice guidelines of the orthopedic section of the American Physical Therapy Association (APTA). * Pain intensity \> 2 on the numerical pain rating scale (NPRS). * Pain that is most intense upon awakening and decreases during walking. • Duration of pain greater than 3 months and less than 7 months. * Both sexes. Exclusion Criteria: * Who have received ankle or foot interventions within the previous three months, such as physical therapy (manual therapy, exercise, physical agents), injections, long-term history of steroid use. * History of surgery on the ankle, foot, or inner leg. * Other causes of heel pain: arthritic (fibromyalgia, gout, rheumatoid arthritis, seronegative spondyloarthropathies), infectious (diabetic ulcers, osteomyelitis, plantar warts), neurological (lumbar radiculopathy (L4-S2), nerve entrapment (branches of posterior tibial nerve), neuroma, tarsal tunnel syndrome, (posterior tibial nerve), trauma (calcaneal stress fracture), tumor (Ewing's sarcoma, neuroma), vascular and pregnancy.
Where this trial is running
Talca, Maule Region
- Clinical Research Laboratory, Department of Physical Therapy, Faculty of Health Sciences — Talca, Maule Region, Chile (RECRUITING)
Study contacts
- Study coordinator: Ignacio Andrés Gajardo Valenzuela, Magíster
- Email: igajardovalen@gmail.com
- Phone: +56993263470
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Plantar Fasciitis of Both Feet, Plantar fasciitis, Myofascial release, manual therapy